Stock TXMD THERAPEUTICSMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.22 USD +4.23% Intraday chart for TherapeuticsMD, Inc. +3.74% -1.33%
May. 10 TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TherapeuticsMD: Q1 Earnings Snapshot
AQ
TherapeuticsMD Announces First Quarter 2024 Financial Results
BU
TherapeuticsMD Announces Full Year 2023 Financial Results
AQ
TherapeuticsMD Announces Full Year 2023 Financial Results
BU
TherapeuticsMD: Q3 Earnings Snapshot
AQ
TherapeuticsMD Announces Third Quarter 2023 Financial Results
BU
TherapeuticsMD: Q2 Earnings Snapshot
AQ
TherapeuticsMD Announces Second Quarter 2023 Financial Results
BU
TherapeuticsMD : Change in Certifying Accountants - Form 8-K
PU
TherapeuticsMD: Q1 Earnings Snapshot
AQ
THERAPEUTICSMD, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
TherapeuticsMD Announces First Quarter 2023 Financial Results
BU
NEUROBO PHARMACEUTICALS, INC. APPOINTS PHARMACEUTICAL INDUSTRY EXECUTIVE, MARK A. GLICKMAN, TO ITS BOARD OF DIRECTORS
AQ
THERAPEUTICSMD, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
THERAPEUTICSMD, INC. : Other Events (form 8-K)
AQ
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
AQ
THERAPEUTICSMD, INC. Management's discussion and analysis of financial condition and results of operations (form 10-K)
AQ
THERAPEUTICSMD, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure (form 8-K)
AQ
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
BU
THERAPEUTICSMD, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TXMD Stock
  4. News TherapeuticsMD, Inc.
  5. Press Releases